clinicalTrials.govIdentifier

URI: https://gptkb.org/prop/clinicalTrials.govIdentifier
11 triples
GPTKB property
Random triples
Subject Object
gptkb:SURPASS-3 NCT03882970
gptkb:A_Study_of_Pembrolizumab_(MK-3475)_in_Combination_With_Axitinib_as_First-Line_Treatment_for_Locally_Advanced_or_Metastatic_Renal_Cell_Carcinoma_(MK-3475-426/KEYNOTE-426) NCT02853331
gptkb:NCT01396499 gptkb:NCT01396499
gptkb:Canakinumab_Anti-inflammatory_Thrombosis_Outcomes_Study gptkb:NCT01327846
gptkb:SURPASS-5 NCT04039503
gptkb:FELIX_study NCT03701022
gptkb:SURPASS-2 NCT03987919
gptkb:EPOC16_(SIBO) NCT04231222
gptkb:NCT00239681 gptkb:NCT00239681
gptkb:A_Study_of_RO5185426_(PLX4032)_in_Previously_Treated_Patients_With_Metastatic_Melanoma NCT00949702
gptkb:A_Study_of_Donanemab_(LY3002813)_in_Participants_With_Preclinical_Alzheimer’s_Disease_(TRAILBLAZER-ALZ_3) NCT05026866